Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity

Details for Australian Patent Application No. 2004232939 (hide)

Owner Merck & Co., Inc. Merck Sharp & Dohme Limited

Inventors Pasternak, Alexander; Moyes, Christopher R.; Goble, Stephen D.; Yang, Lihu; Butora, Gabor; Zhou, Changyou

Agent Spruson & Ferguson

Pub. Number AU-A-2004232939

PCT Pub. Number WO2004/094371

Priority 60/463,673 17.04.03 US

Filing date 14 April 2004

Wipo publication date 4 November 2004

International Classifications

C07D 515/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

3 November 2005 PCT application entered the National Phase

  PCT publication WO2004/094371 Priority application(s): WO2004/094371

13 May 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Limited; Merck Sharp & Dohme Corp.

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232941-Piperazine containing phosphonic acid compounds as inhibitors of serine proteases

2004232936-Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers